|
|
||||
|
|
||||
|
||||
Tumor Biology |
Department of Pathology and Laboratory Medicine (D.J.B.) and Laboratory of Molecular Neuro-Oncology, Departments of Neurosurgery and Hematology/Oncology, and Winship Cancer Institute (A.C.B., E.G.V.M.), Emory University School of Medicine, Atlanta, GA 30322, USA
2 Send correspondence to Erwin G. Van Meir, Laboratory of Molecular Neuro-Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365-C Clifton Road NE, Room C-5078, Atlanta, GA 30322, USA (evanmei{at}emory.edu).
Abstract
Interleukin-8 (IL-8, or CXCL8), which is a chemokine with a defining CXC
amino acid motif that was initially characterized for its leukocyte
chemotactic activity, is now known to possess tumorigenic and proangiogenic
properties as well. In human gliomas, IL-8 is expressed and secreted at high
levels both in vitro and in vivo, and recent experiments suggest it is
critical to glial tumor neovascularity and progression. Levels of IL-8
correlate with histologic grade in glial neoplasms, and the most malignant
form, glioblastoma, shows the highest expression in pseudopalisading cells
around necrosis, suggesting that hypoxia/anoxia may stimulate expression. In
addition to hypoxia/anoxia stimulation, increased IL-8 in gliomas occurs in
response to Fas ligation, death receptor activation, cytosolic
Ca2+, TNF-
, IL-1, and other cytokines and various cellular
stresses. The IL-8 promoter contains binding sites for the transcription
factors NF-
B, AP-1, and C-EBP/NF-IL-6, among others. AP-1 has been
shown to mediate IL-8 upregulation by anoxia in gliomas. The potential tumor
suppressor ING4 was recently shown to be a critical regulator of
NF-
B-mediated IL-8 transcription and subsequent angiogenesis in
gliomas. The IL-8 receptors that could contribute to IL-8-mediated tumorigenic
and angiogenic responses include CXCR1 and CXCR2, both of which are G-protein
coupled, and the Duffy antigen receptor for cytokines, which has no defined
intracellular signaling capabilities. The proangiogenic activity of IL-8
occurs predominantly following binding to CXCR2, but CXCR1 appears to
contribute as well through independent, small-GTPase activity. A precise
definition of the mechanisms by which IL-8 exerts its proangiogenic functions
requires further study for the development of effective IL-8-targeted
therapies.
References
Addison, C.L., Daniel, T.O., Burdick, M.D., Liu, H., Ehlert, J.E.,
Xue, Y.Y., Buechi, L., Walz, A., Richmond, A., and Strieter, R.M.
(2000) The CXC chemokine receptor 2, CXCR2, is the putative
receptor for ELR+ CXC chemokine-induced angiogenic activity. J.
Immunol. 165,5269
-5277.
Ahuja, S.K., Ozcelik, T., Milatovitch, A., Francke, U., and Murphy, P.M. (1992) Molecular evolution of the human interleukin-8 receptor gene cluster. Nat. Genet. 2, 31-36.[CrossRef][Web of Science][Medline]
Ahuja, S.K., Shetty, A., Tiffany, H.L., and Murphy, P.M.
(1994) Comparison of the genomic organization and promoter
function for human interleukin-8 receptors A and B. J. Biol.
Chem. 269,26381
-26389.
Ahuja, S.K., and Murphy, P.M. (1996) The CXC
chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma,
neutrophil ac tivating peptide-2, and epithelial cell-derived
neutrophil-activating peptide-78 are potent agonists for the type B, but not
the type A, human interleukin-8 receptor. J. Biol.
Chem. 271,20545
-20550.
Baggiolini, M., Walz, A., and Kunkel, S.L. (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84,1045 -1049.
Baggiolini, M., Dewald, B., and Moser, B. (1994) Interleukin-8 and related chemotactic cytokinesCXC and CC chemokines. Adv. Immunol. 55,97 -179.[Web of Science][Medline]
Baggiolini, M., Dewald, B., and Moser, B. (1997) Human chemokines: An update. Annu. Rev. Immunol. 15,675 -705.[CrossRef][Web of Science][Medline]
Balkwill, F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4,540 -550.[CrossRef][Web of Science][Medline]
Biancone, L., Martino, A.D., Orlandi, V., Conaldi, P.G., Toniolo,
A., and Camussi, G. (1997) Development of inflammatory
angiogenesis by local stimulation of Fas in vivo. J. Exp.
Med. 186,147
-152.
Bobrovnikova-Marjon, E.V., Marjon, P.L., Barbash, O., Vander Jagt,
D.L., and Abcouwer, S.F. (2004) Expression of angiogenic factors
vascular endothelial growth factor and interleukin-8/CXCL8 is highly
responsive to ambient glutamine availability: Role of nuclear factor-kappaB
and activating protein-1. Cancer Res.
64,4858
-4869.
Brat, D.J., and Van Meir, E.G. (2001) Glomeruloid
microvascular proliferation orchestrated by VPF/VEGF: A new world of
angiogenesis research. Am. J. Pathol.
158,789
-796.
Brat, D.J., Kaur, B., and Van Meir, E.G. (2003) Genetic modulation of hypoxia induced gene expression and angiogenesis: Relevance to brain tumors. Front. Biosci. 8,D100 -D116.
Chen, J.J., Sun, Y., and Nabel, G.J. (1998) Regulation
of the proinflammatory effects of Fas ligand (CD95L).
Science 282,1714
-1717.
Chen, J.J., Yao, P.L., Yuan, A., Hong, T.M., Shun, C.T., Kuo, M.L.,
Lee, Y.C., and Yang, P.C. (2003) Up-regulation of tumor
interleukin-8 expression by infiltrating macrophages: Its correlation with
tumor angiogenesis and patient survival in non-small cell lung cancer.
Clin. Cancer Res. 9,729
-737.
Choi, C., Xu, X., Oh, J.W., Lee, S.J., Gillespie, G.Y., Park, H.,
Jo, H., and Ben veniste, E.N. (2001) Fas-induced expression of
chemokines in human glioma cells: Involvement of extracellular
signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
Cancer Res. 61,3084
-3091.
Choi, C., Kutsch, O., Park, J., Zhou, T., Seol, D.W., and
Benveniste, E.N. (2002) Tumor necrosis factor-related
apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression
and apoptosis in human astroglioma cells. Mol. Cell.
Biol. 22,724
-736.
Clark-Lewis, I., Dewald, B., Geiser, T., Moser, B., and Baggiolini,
M. (1993) Platelet factor 4 binds to interleukin 8 receptors and
activates neutro phils when its N terminus is modified with Glu-Leu-Arg.
Proc. Natl. Acad. Sci. USA
90,3574
-3577.
DeForge, L.E., Preston, A.M., Takeuchi, E., Kenney, J., Boxer,
L.A., and Remick, D.G. (1993) Regulation of interleukin 8 gene
expression by oxi dant stress. J. Biol. Chem.
268,25568
-25576.
De Larco, J.E., Wuertz, B.R., Yee, D., Rickert, B.L., and Furcht,
L.T. (2003) Atypical methylation of the interleukin-8 gene
correlates strongly with the metastatic potential of breast carcinoma cells.
Proc. Natl. Acad. Sci. USA
100,13988
-13993.
del Pozo, M.A., Price, L.S., Alderson, N.B., Ren, X.-D., and Schwartz, M.A. (2000) Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J. 19,2008 -2014.[CrossRef][Web of Science][Medline]
Desbaillets, I., Diserens, A.C., Tribolet, N., Hamou, M.F., and Van
Meir, E.G. (1997) Upregulation of interleukin 8 by
oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation,
chemotaxis, and angiogenesis. J. Exp. Med.
186,1201
-1212.
Desbaillets, I., Diserens, A.C., de Tribolet, N., Hamou, M.F., and Van Meir, E.G. (1999) Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18,1447 -1456.[CrossRef][Web of Science][Medline]
Flynn, G., Maru, S., Loughlin, J., Romero, I.A., and Male, D. (2003) Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136, 84-93.[CrossRef][Web of Science][Medline]
Garkavtsev, I., Kozin, S.V., Chernova, O., Xu, L., Winkler, F., Brown, E., Barnett, G.H., and Jain, R.K. (2004) The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428,328 -332.[CrossRef][Medline]
Gratas, C., Tohma, Y., Van Meir, E.G., Klein, M., Tenan, M., Ishii, N., Tachibana, O., Kleihues, P., and Ohgaki, H. (1997) Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol. 7,863 -869.[Web of Science][Medline]
Harada, A., Sekido, N., Akahoshi, T., Wada, T., Mukaida, N., and Matsu shima, K. (1994) Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 56,559 -564.[Abstract]
Hebert, C.A., and Baker, J.B. (1993) Interleukin-8: A review. Cancer Invest. 11,743 -750.[Web of Science][Medline]
Heidemann, J., Ogawa, H., Dwinell, M.B., Rafiee, P., Maaser, C.,
Gockel, H.R., Otterson, M.F., Ota, D.M., Lugering, N., Domschke, W., and Bin
ion, D.G. (2003) Angiogenic effects of interleukin 8 (CXCL8) in
human intestinal microvascular endothelial cells are mediated by CXCR2.
J. Biol. Chem. 278,8508
-8515.
Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H., and Kracht, M.
(2002) Multiple control of interleukin-8 gene expression.
J. Leukoc. Biol. 72,847
-855.
Holmes, W.E., Lee, J., Kuang, W.J., Rice, G.C., and Wood, W.I.
(1991) Structure and functional expression of a human
interleukin-8 receptor. Science
253,1278
-1280.
Holtmann, H., Winzen, R., Holland, P., Eickemeier, S., Hoffmann,
E., Wal lach, D., Malinin, N.L., Cooper, J.A., Resch, K., and Kracht, M.
(1999) Induction of interleukin-8 synthesis integrates effects on
transcription and mRNA degradation from at least three different cytokine or
stress-activated signal transduction pathways. Mol. Cell.
Biol. 19,6742
-6753.
Holtmann, H., Enninga, J., Kalble, S., Thiefes, A., Dorrie, A.,
Broemer, M., Winzen, R., Wilhelm, A., Ninomiya-Tsuji, J., Matsumoto, K.,
Resch, K., and Kracht, M. (2001) The MAPK kinase kinase TAK1
plays a central role in coupling the interleukin-1 receptor to both
transcriptional and RNA-targeted mechanisms of gene regulation. J.
Biol. Chem. 276,3508
-3516.
Hor, W.S., Huang, W.L., Lin, Y.S., and Yang, B.C.
(2003) Cross-talk between tumor cells and neutrophils through the
Fas (APO-1, CD95)/FasL system: Human glioma cells enhance cell viability and
stimulate cytokine production in neutrophils. J. Leukoc.
Biol. 73,363
-368.
Horcher, M., Rot, A., Aschauer, H., and Besemer, J. (1998) IL-8 derivatives with a reduced potential to form homodimers are fully active in vitro and in vivo. Cytokine 10,1 -12.[CrossRef][Web of Science][Medline]
Horuk, R., Chitnis, C.E., Darbonne, W.C., Colby, T.J., Rybicki, A.,
Had ley, T.J., and Miller, L.H. (1993) A receptor for the
malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor.
Science 261,1182
-1184.
Hu, D.E., Hori, Y., and Fan, T.P. (1993) Interleukin-8 stimulates angiogen esis in rats. Inflammation 17,135 -143.[CrossRef][Web of Science][Medline]
Huang, S., Pettaway, C.A., Uehara, H., Bucana, C.D., and Fidler, I.J. (2001) Blockade of NF-kappaB activity in human prostate cancer cells is asso ciated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20,4188 -4197.[CrossRef][Web of Science][Medline]
Kasahara, T., Mukaida, N., Yamashita, K., Yagisawa, H., Akahoshi, T., and Matsushima, K. (1991) IL-1 and TNF-alpha induction of IL-8 and mono cyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74, 60-67.[Web of Science][Medline]
Koch, A.E., Polverini, P.J., Kunkel, S.L., Harlow, L.A., DiPietro,
L.A., Elner, V.M., Elner, S.G., and Strieter, R.M. (1992)
Interleukin-8 as a macrophage-derived mediator of angiogenesis.
Science 258,1798
-1801.
Kuhns, D.B., Young, H.A., Gallin, E.K., and Gallin, J.I.
(1998) Ca2+-dependent production and release of IL-8
in human neutrophils. J. Immunol.
161,4332
-4339.
Kunsch, C., and Rosen, C.A. (1993) NF-kappa B
subunit-specific regulation of the interleukin-8 promoter. Mol.
Cell. Biol. 13,6137
-6146.
Lakshminarayanan, V., Drab-Weiss, E.A., and Roebuck, K.A.
(1998) H2O2 and tumor necrosis factor-alpha
induce differential binding of the redox-responsive transcription factors AP-1
and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial
cells. J. Biol. Chem.
273,32670
-32678.
Lee, Y.B., Nagai, A., and Kim, S.U. (2002) Cytokines, chemokines, and cytokine receptors in human microglia. J. Neurosci. Res. 69,94 -103.[CrossRef][Web of Science][Medline]
Li, A., Dubey, S., Varney, M.L., Dave, B.J., and Singh, R.K.
(2003) IL-8 directly enhanced endothelial cell survival,
proliferation, and matrix metalloproteinases production and regulated
angiogenesis. J. Immunol.
170,3369
-3376.
Loetscher, M., Gerber, B., Loetscher, P., Jones, S.A., Piali, L.,
Clark-Lewis, I., Baggiolini, M., and Moser, B. (1996) Chemokine
receptor specific for IP10 and Mig: Structure, function, and expression in
activated T-lymphocytes. J. Exp. Med.
184,963
-969.
Mahe, Y., Mukaida, N., Kuno, K., Akiyama, M., Ikeda, N.,
Matsushima, K., and Murakami, S. (1991) Hepatitis B virus X
protein transactivates human interleukin-8 gene through acting on nuclear
factor kB and CCAAT/enhancer-binding protein-like cis-elements. J.
Biol. Chem. 266,13759
-13763.
Maione, T.E., Gray, G.S., Petro, J., Hunt, A.J., Donner, A.L.,
Bauer, S.I., Carson, H.F., and Sharpe, R.J. (1990) Inhibition of
angiogenesis by recombinant human platelet factor-4 and related peptides.
Science 247,77
-79.
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima,
K., Kishimoto, T., and Akira, S. (1993) Transcription factors
NF-IL6 and NF-kappa B synergistically activate transcription of the
inflammatory cytokines, interleukin 6 and interleukin 8. Proc.
Natl. Acad. Sci. USA 90,10193
-10197.
Matsushima, K., and Oppenheim, J.J. (1989) Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1,2 -13.[CrossRef][Medline]
Moore, B.B., Arenberg, D.A., Addison, C.L., Keane, M.P., and Strieter, R.M. (1998) Tumor angiogenesis is regulated by CXC chemokines. J. Lab. Clin. Med. 132,97 -103.[CrossRef][Web of Science][Medline]
Morita, M., Kasahara, T., Mukaida, N., Matsushima, K., Nagashima, T., Nishizawa, M., and Yoshida, M. (1993) Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues. Eur. Cytokine Netw. 4, 351-358.[Web of Science][Medline]
Mukaida, N., Mahe, Y., and Matsushima, K. (1990)
Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer
binding protein-like factor binding elements in activating the interleukin-8
gene by pro inflammatory cytokines. J. Biol. Chem.
265,21128
-21133.
Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S.,
Kasahara, T., and Matsushima, K. (1994) Novel mechanism of
glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for
gluco corticoid-mediated interleukin 8 gene repression. J. Biol.
Chem. 269,13289
-13295.
Murdoch, C., Monk, P.N., and Finn, A. (1999) CXC chemokine receptor expression on human endothelial cells. Cytokine 11,704 -712.[CrossRef][Web of Science][Medline]
Murphy, P.M., and Tiffany, H.L. (1991) Cloning of
complementary DNA encoding a functional human interleukin-8 receptor.
Science 253,1280
-1283.
Murphy, P.M., Baggiolini, M., Charo, I.F., Hebert, C.A., Horuk, R.,
Matsu shima, K., Miller, L.H., Oppenheim, J.J., and Power, C.A.
(2000) International union of pharmacology. XXII. Nomenclature
for chemokine receptors. Pharmacol. Rev.
52,145
-176.
Nabors, L.B., Suswam, E., Huang, Y., Yang, X., Johnson, M.J., and
King, P.H. (2003) Tumor necrosis factor alpha induces angiogenic
factor up-regulation in malignant glioma cells: A role for RNA stabilization
and HuR. Cancer Res. 63,4181
-4187.
Neote, K., Darbonne, W., Ogez, J., Horuk, R., and Schall, T.J.
(1993) Identi fication of a promiscuous inflammatory peptide
receptor on the surface of red blood cells. J. Biol.
Chem. 268,12247
-12249.
Nishie, A., Ono, M., Shono, T., Fukushi, J., Otsubo, M., Onoue, H.,
Ito, Y., Inamura, T., Ikezaki, K., Fukui, M., Iwaki, T., and Kuwano, M.
(1999) Macrophage infiltration and heme oxygenase-1 expression
correlate with angiogenesis in human gliomas. Clin. Cancer
Res. 5,1107
-1113.
Norrby, K. (1996) Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif. 29,315 -323.[Web of Science][Medline]
Rajarathnam, K., Sykes, B.D., Kay, C.M., Dewald, B., Geiser, T.,
Baggio lini, M., and Clark-Lewis, I. (1994) Neutrophil activation
by monomeric interleukin-8. Science
264, 90-92.
Roebuck, K.A. (1999) Regulation of interleukin-8 gene expression. J. Interferon Cytokine Res. 19,429 -438.[CrossRef][Web of Science][Medline]
Rossi, D., and Zlotnik, A. (2000) The biology of chemokines and their receptors. Annu. Rev. Immunol. 18,217 -242.[CrossRef][Web of Science][Medline]
Saas, P., Walker, P.R., Hahne, M., Quiquerez, A.L., Schnuriger, V., Perrin, G., French, L., Van Meir, E.G., de Tribolet, N., Tschopp, J., and Dietrich, P.Y. (1997) Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain? J. Clin. Invest. 99,1173 -1178.[Web of Science][Medline]
Saas, P., Boucraut, J., Quiquerez, A.L., Schnuriger, V., Perrin,
G., Desplat-Jego, S., Bernard, D., Walker, P.R., and Dietrich, P.Y.
(1999) CD95 (Fas/Apo-1) as a receptor governing astrocyte
apoptotic or inflammatory responses: A key role in brain inflammation?
J. Immunol. 162,2326
-2333.
Salcedo, R., Resau, J.H., Halverson, D., Hudson, E.A., Dambach, M.,
Pow ell, D., Wasserman, K., and Oppenheim, J.J. (2000)
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by
human microvascular endothelial cells and umbilical vein endothelial cells.
FASEB J. 14,2055
-2064.
Schraufstatter, I.U., Chung, J., and Burger, M. (2001)
IL-8 activates endo thelial cell CXCR1 and CXCR2 through Rho and Rac signaling
path ways. Am. J. Physiol. Lung Cell. Mol. Physiol.
280,L1094
-L1103.
Schraufstatter, I.U., Trieu, K., Zhao, M., Rose, D.M., Terkeltaub,
R.A., and Burger, M. (2003) IL-8-mediated cell migration in
endothelial cells depends on cathepsin B activity and transactivation of the
epidermal growth factor receptor. J. Immunol.
171,6714
-6722.
Shi, Q., Le, X., Abbruzzese, J.L., Wang, B., Mujaida, N., Matsushima, K., Huang, S., Xiong, Q., and Xie, K. (1999) Cooperation between tran scription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. J. Interferon Cyto kine Res. 19,1363 -1371.
Shi, Q., Le, X., Wang, B., Xiong, Q., Abbruzzese, J.L., and Xie, K. (2000) Regulation of interleukin-8 expression by cellular pH in human pancre atic adenocarcinoma cells. J. Interferon Cytokine Res. 20,1023 -1028.[CrossRef][Web of Science][Medline]
Shono, T., Ono, M., Izumi, H., Jimi, S.I., Matsushima, K., Okamoto, T., Kohno, K., and Kuwano, M. (1996) Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol. 16,4231 -4239.[Abstract]
Smyth, M.J., Zachariae, C.O., Norihisa, Y., Ortaldo, J.R., Hishinuma, A., and Matsushima, K. (1991) IL-8 gene expression and production in human peripheral blood lymphocyte subsets. J. Immunol. 146,3815 -3823.[Abstract]
Song, J.H., Song, D.K., Pyrzynska, B., Petruk, K.C., Van Meir, E.G., and Hao, C. (2003) TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways. Brain Pathol. 13,539 -553.[Web of Science][Medline]
Sotsios, Y., and Ward, S.G. (2000) Phosphoinositide 3-kinase: A key bio chemical signal for cell migration in response to chemokines. Immunol. Rev. 177,217 -235.[CrossRef][Web of Science][Medline]
Strieter, R.M. (2001) Chemokines: Not just leukocyte chemoattractants in the promotion of cancer. Nat. Immunol. 2,285 -286.[CrossRef][Web of Science][Medline]
Strieter, R.M., Kunkel, S.L., Showell, H.J., Remick, D.G., Phan,
S.H., Ward, P.A., and Marks, R.M. (1989) Endothelial cell gene
expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1
beta. Science 243,1467
-1469.
Strieter, R.M., Kunkel, S.L., Elner, V.M., Martonyi, C.L., Koch, A.E., Pol verini, P.J., and Elner, S.G. (1992) Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141,1279 -1284.[Abstract]
Strieter, R.M., Polverini, P.J., Kunkel, S.L., Arenberg, D.A.,
Burdick, M.D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D.,
Chan, S.-Y., Roczniak, S., and Shanafelt, A.B. (1995) The
functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
J. Biol. Chem. 270,27348
-27357.
Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. (1994) Macrophages and angiogenesis. J. Leukoc. Biol. 55,410 -422.[Abstract]
Szekanecz, Z., Shah, M.R., Harlow, L.A., Pearce, W.H., and Koch, A.E. (1994) Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cyto kines in human aortic aneurysmal blood vessel growth, Pathobiology 62,134 -139.[Web of Science][Medline]
Tada, M., Suzuki, K., Yamakawa, Y., Sawamura, Y., Sakuma, S., Abe, H., van Meir, E., and de Tribolet, N. (1993) Human glioblastoma cells produce 77 amino acid interleukin-8 (IL-8(77)). J. Neurooncol. 16,25 -34.[CrossRef][Medline]
Tanaka, C., Kamata, H., Takeshita, H., Yagisawa, H., and Hirata, H. (1997) Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NF kappa B and AP-1 in human astrocytoma U373 cells. Biochem. Biophys. Res. Commun. 232,568 -573.[CrossRef][Web of Science][Medline]
Tebo, J., Der, S., Frevel, M., Khabar, K.S., Williams, B.R., and
Hamilton, T.A. (2003) Heterogeneity in control of mRNA stability
by AU-rich elements. J. Biol. Chem.
278,12085
-12093.
Tournamille, C., Blancher, A., Le Van Kim, C., Gane, P., Apoil, P.A., Naka moto, W., Cartron, J.P., and Colin, Y. (2004) Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines. Immunogenetics 55,682 -694.[CrossRef][Web of Science][Medline]
Trushin, S.A., Pennington, K.N., Algeciras-Schimnich, A., and Paya,
C.V. (1999) Protein kinase C and calcineurin synergize to
activate IkappaB kinase and NF-kappaB in T lymphocytes. J. Biol.
Chem. 274,22923
-22931.
Van Meir, E.G. (1995) Cytokines and tumors of the central nervous system. Glia 15,264 -288.[CrossRef][Web of Science][Medline]
Van Meir, E.G., Ceska, M., Effenberger, F., Walz, A., Grouzmann,
E., Desbaillets, I., Frei, K., Fontana, A., and de Tribolet, N.
(1992) Interleukin-8 is produced in neoplastic and infectious
diseases of the human central nervous system. Cancer
Res. 52,4297
-4305.
Van Meir, E.G., Hao, C., Post, D.E., Liau, L.M., and Brat, D.J. (2003) Therapeutic targeting of the pathways that induce brain tumor development. Chapter 18 in Zhang, W., and Fuller, G.N. (Eds.) Genomic and Molecular Neuro-Oncology. Sudbury, Mass.: Jones and Bartlett Publishers, pp.303 -332.
Vicari, A.P., and Caux, C. (2002) Chemokines in cancer. Cytokine Growth Factor Rev. 13,143 -154.[CrossRef][Web of Science][Medline]
Wakabayashi, K., Kambe, F., Cao, X., Murakami, R., Mitsuyama, H., Nagaya, T., Saito, K., Yoshida, J., and Seo, H. (2004) Inhibitory effects of cyclosporin A on calcium mobilization-dependent interleukin-8 expression and invasive potential of human glioblastoma U251MG cells. Oncogene 23,6924 -6932.[CrossRef][Web of Science][Medline]
Walz, A., Peveri, P., Aschauer, H., and Baggiolini, M. (1987) Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 149,755 -761.[CrossRef][Web of Science][Medline]
Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C.Y., Shyu, A.B., Muller, M., Gaestel, M., Resch, K., and Holtmann, H. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18,4969 -4980.[CrossRef][Web of Science][Medline]
Winzen, R., Gowrishankar, G., Bollig, F., Redich, N., Resch, K.,
and Holtmann, H. (2004) Distinct domains of AU-rich elements
exert different functions in mRNA destabilization and stabilization by p38
mitogen-activated protein kinase or HuR. Mol. Cell.
Biol. 24,4835
-4847.
Wolf, M., Delgado, M.B., Jones, S.A., Dewald, B., Clark-Lewis, I., and Bag giolini, M. (1998) Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur. J. Immunol. 28,164 -170.[CrossRef][Web of Science][Medline]
Xie, K. (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12,375 -391.[CrossRef][Web of Science][Medline]
Yamamoto, Y., and Gaynor, R.B. (2004) I
B
kinases: Key regulators of the NF-
B pathway. Trends Biochem.
Sci. 29,72
-79.[CrossRef][Web of Science][Medline]
Yamanaka, R., Tanaka, R., Yoshida, S., Saitoh, T., and Fujita, K. (1995) Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8. J. Neurooncol. 25,59 -65.[CrossRef][Medline]
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E.A., Appella,
E., Oppenheim, J.J., and Leonard, E.J. (1987) Purification of a
human monocyte-derived neutrophil chemotactic factor that has peptide sequence
similarity to other host defense cytokines. Proc. Natl. Acad. Sci.
USA 84,9233
-9237.
Zhou, Y., Larsen, P.H., Hao, C., and Yong, V.W. (2002)
CXCR4 is a major chemokine receptor on glioma cells and mediates their
survival. J. Biol. Chem.
277,49481
-49487.
This article has been cited by other articles:
![]() |
S. Shinriki, H. Jono, K. Ota, M. Ueda, M. Kudo, T. Ota, Y. Oike, M. Endo, M. Ibusuki, A. Hiraki, et al. Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma Clin. Cancer Res., September 1, 2009; 15(17): 5426 - 5434. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Hao, L. Wang, and H. Tang Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells Am J Physiol Cell Physiol, April 1, 2009; 296(4): C821 - C827. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fang, L.-B. Luo, Y.-M. Tao, F. Wu, and L.-Y. Yang Decreased Expression of Inhibitor of Growth 4 Correlated with Poor Prognosis of Hepatocellular Carcinoma Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 409 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wilson, C. Purcell, A. Seaton, O. Oladipo, P. J. Maxwell, J. M. O'Sullivan, R. H. Wilson, P. G. Johnston, and D. J. J. Waugh Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor-{kappa}B Transcription and Evasion of Apoptosis J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 746 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H.E. Baker, J. Lam, A. H. Kyle, J. Sy, T. Oliver, S. J. Co, W. H. Dragowska, E. Ramsay, M. Anantha, T. J. Ruth, et al. Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin Clin. Cancer Res., November 15, 2008; 14(22): 7260 - 7271. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J.J. Waugh and C. Wilson The Interleukin-8 Pathway in Cancer Clin. Cancer Res., November 1, 2008; 14(21): 6735 - 6741. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Goczalik, E. Ulbricht, M. Hollborn, M. Raap, S. Uhlmann, M. Weick, T. Pannicke, P. Wiedemann, A. Bringmann, A. Reichenbach, et al. Expression of CXCL8, CXCR1, and CXCR2 in Neurons and Glial Cells of the Human and Rabbit Retina Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4578 - 4589. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Weik, A. Herforth, V. Kolb-Bachofen, and R. Deinzer Acute Stress Induces Proinflammatory Signaling at Chronic Inflammation Sites Psychosom Med, October 1, 2008; 70(8): 906 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sjolinder, L. Lovkvist, L. Plant, J. Eriksson, H. Aro, A. Jones, and A.-B. Jonsson The ScpC Protease of Streptococcus pyogenes Affects the Outcome of Sepsis in a Murine Model Infect. Immun., September 1, 2008; 76(9): 3959 - 3966. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Fernandes, J. Zhou, X. Zhang, Q. Bian, J. Sparrow, A. Taylor, P. Pereira, and F. Shang Oxidative Inactivation of the Proteasome in Retinal Pigment Epithelial Cells: A POTENTIAL LINK BETWEEN OXIDATIVE STRESS AND UP-REGULATION OF INTERLEUKIN-8 J. Biol. Chem., July 25, 2008; 283(30): 20745 - 20753. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. de la Iglesia, G. Konopka, K.-L. Lim, C. L. Nutt, J. F. Bromberg, D. A. Frank, P. S. Mischel, D. N. Louis, and A. Bonni Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness J. Neurosci., June 4, 2008; 28(23): 5870 - 5878. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Abdel-Malak, C. B. Srikant, A. S. Kristof, S. A. Magder, J. A. Di Battista, and S. N. A. Hussain Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8 Blood, April 15, 2008; 111(8): 4145 - 4154. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sarkar, E. S. Park, L. Emdad, S.-G. Lee, Z.-z. Su, and P. B. Fisher Molecular Basis of Nuclear Factor-{kappa}B Activation by Astrocyte Elevated Gene-1 Cancer Res., March 1, 2008; 68(5): 1478 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Suswam, Y. Li, X. Zhang, G. Y. Gillespie, X. Li, J. J. Shacka, L. Lu, L. Zheng, and P. H. King Tristetraprolin Down-regulates Interleukin-8 and Vascular Endothelial Growth Factor in Malignant Glioma Cells Cancer Res., February 1, 2008; 68(3): 674 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choi and J.N. Myers Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy Journal of Dental Research, January 1, 2008; 87(1): 14 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Colla, S. Tagliaferri, F. Morandi, P. Lunghi, G. Donofrio, D. Martorana, C. Mancini, M. Lazzaretti, L. Mazzera, L. Ravanetti, et al. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 {alpha} (HIF-1{alpha}) activity: involvement in myeloma-induced angiogenesis Blood, December 15, 2007; 110(13): 4464 - 4475. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhong, B. Han, I. L. Tourkova, A. Lokshin, A. Rosenbloom, M. R. Shurin, and G. V. Shurin Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth Clin. Cancer Res., September 15, 2007; 13(18): 5455 - 5462. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Binsky, M. Haran, D. Starlets, Y. Gore, F. Lantner, N. Harpaz, L. Leng, D. M. Goldenberg, L. Shvidel, A. Berrebi, et al. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival PNAS, August 14, 2007; 104(33): 13408 - 13413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Giorgini, D. Trisciuoglio, C. Gabellini, M. Desideri, L. Castellini, C. Colarossi, U. Zangemeister-Wittke, G. Zupi, and D. Del Bufalo Modulation of bcl-xL in Tumor Cells Regulates Angiogenesis through CXCL8 Expression Mol. Cancer Res., August 1, 2007; 5(8): 761 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Araki, Y. Omori, D. Lyn, R. K. Singh, D. M. Meinbach, Y. Sandman, V. B. Lokeshwar, and B. L. Lokeshwar Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate Cancer Cancer Res., July 15, 2007; 67(14): 6854 - 6862. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Govindaraju, M.-C. Michoud, M. Al-Chalabi, P. Ferraro, W. S. Powell, and J. G. Martin Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration Am J Physiol Cell Physiol, November 1, 2006; 291(5): C957 - C965. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qi, X. Chen, J. Holian, E. Mreich, S. Twigg, R. E. Gilbert, and C. A. Pollock Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1070 - F1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Rong, F. Hu, R. Huang, N. Mackman, J. M. Horowitz, R. L. Jensen, D. L. Durden, E. G. Van Meir, and D. J. Brat Early Growth Response Gene-1 Regulates Hypoxia-Induced Expression of Tissue Factor in Glioblastoma Multiforme through Hypoxia-Inducible Factor-1-Independent Mechanisms. Cancer Res., July 15, 2006; 66(14): 7067 - 7074. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, D. He, B. Saatian, T. Watkins, E. Wm. Spannhake, N. J. Pyne, and V. Natarajan Regulation of Lysophosphatidic Acid-induced Epidermal Growth Factor Receptor Transactivation and Interleukin-8 Secretion in Human Bronchial Epithelial Cells by Protein Kinase C{delta}, Lyn Kinase, and Matrix Metalloproteinases J. Biol. Chem., July 14, 2006; 281(28): 19501 - 19511. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Charalambous, L. B. Pen, Y. S. Su, J. Milan, T. C. Chen, and F. M. Hofman Interleukin-8 Differentially Regulates Migration of Tumor-Associated and Normal Human Brain Endothelial Cells Cancer Res., November 15, 2005; 65(22): 10347 - 10354. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|